The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Giancarlo Comi

University Vita-Salute San Raffaele

Department of Neurology and Institute of Experimental Neurology

Via Olgettina 60

20132 Milan

Italy

[email]@hsr.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • University Vita-Salute San Raffaele, Department of Neurology and Institute of Experimental Neurology, Via Olgettina 60, 20132 Milan, Italy. 2013
  • Department of Neurology, Ospedale San Raffaele, Milan, Italy. 2005 - 2012
  • Institute of Experimental Neurology, Department of Neurology, University Vita-Salute, Scientific Institute San Raffaele, Italy. 2006 - 2011
  • Department of Neurophysiopathology, Scientific Institute Ospedale San Raffaele, Via Olgettina 60, 20132, Italy. 1999 - 2008
  • Department of Clinical Neurophysiology, S. Raffaele Hospital, University of Milan, Italy. 1999 - 2008
  • Multiple Sclerosis Centre, San Raffaele Scientific Institute, Milan, Italy. 2000

References

  1. Cladribine tablets for the treatment of relapsing-remitting multiple sclerosis. Comi, G., Hartung, H.P., Kurukulasuriya, N.C., Greenberg, S.J., Scaramozza, M. Expert. Opin. Pharmacother (2013) [Pubmed]
  2. Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial. Comi, G., De Stefano, N., Freedman, M.S., Barkhof, F., Polman, C.H., Uitdehaag, B.M., Casset-Semanaz, F., Hennessy, B., Moraga, M.S., Rocak, S., Stubinski, B., Kappos, L. Lancet. Neurol (2012) [Pubmed]
  3. Phase III dose-comparison study of glatiramer acetate for multiple sclerosis. Comi, G., Cohen, J.A., Arnold, D.L., Wynn, D., Filippi, M. Ann. Neurol. (2011) [Pubmed]
  4. Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results. Comi, G., O'Connor, P., Montalban, X., Antel, J., Radue, E.W., Karlsson, G., Pohlmann, H., Aradhye, S., Kappos, L. Mult. Scler. (2010) [Pubmed]
  5. Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial. Comi, G., Martinelli, V., Rodegher, M., Moiola, L., Bajenaru, O., Carra, A., Elovaara, I., Fazekas, F., Hartung, H.P., Hillert, J., King, J., Komoly, S., Lubetzki, C., Montalban, X., Myhr, K.M., Ravnborg, M., Rieckmann, P., Wynn, D., Young, C., Filippi, M. Lancet (2009) [Pubmed]
  6. Is it clinically relevant to repair focal multiple sclerosis lesions? Comi, G. J. Neurol. Sci. (2008) [Pubmed]
  7. Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Comi, G., Pulizzi, A., Rovaris, M., Abramsky, O., Arbizu, T., Boiko, A., Gold, R., Havrdova, E., Komoly, S., Selmaj, K., Sharrack, B., Filippi, M. Lancet (2008) [Pubmed]
  8. Clinically isolated syndrome: the rationale for early treatment. Comi, G. Nature Clinical Practice. Neurology (2008) [Pubmed]
  9. Definition of responder: introduction. Comi, G. Neurol. Sci. (2008) [Pubmed]
  10. MS treatment: new perspectives. Comi, G., Martino, G. Clin. Neurol. Neurosurg (2006) [Pubmed]
  11. Optimisation of immunomodulatory therapies. Comi, G. Neurol. Sci. (2005) [Pubmed]
  12. Clinical trials in multiple sclerosis: methodological issues. Comi, G., Filippi, M. Curr. Opin. Neurol. (2005) [Pubmed]
  13. A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy. Comi, G., Roveri, L., Swan, A., Willison, H., Bojar, M., Illa, I., Karageorgiou, C., Nobile-Orazio, E., van den Bergh, P., Swan, T., Hughes, R., Aubry, J., Baumann, N., Hadden, R., Lunn, M., Knapp, M., Léger, J.M., Bouche, P., Mazanec, R., Meucci, N., van der Meché, F., Toyka, K. J. Neurol. (2002) [Pubmed]
  14. Assessment, pathophysiology and treatment of fatigue in multiple sclerosis. Comi, G., Leocani, L. Expert. Rev. Neurother (2002) [Pubmed]
  15. European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadian Glatiramer Acetate Study Group. Comi, G., Filippi, M., Wolinsky, J.S. Ann. Neurol. (2001) [Pubmed]
  16. Physiopathology and treatment of fatigue in multiple sclerosis. Comi, G., Leocani, L., Rossi, P., Colombo, B. J. Neurol. (2001) [Pubmed]
  17. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Comi, G., Filippi, M., Barkhof, F., Durelli, L., Edan, G., Fernández, O., Hartung, H., Seeldrayers, P., Sørensen, P.S., Rovaris, M., Martinelli, V., Hommes, O.R. Lancet (2001) [Pubmed]
  18. Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation. BMT-MS Study Group. Comi, G., Kappos, L., Clanet, M., Ebers, G., Fassas, A., Fazekas, F., Filippi, M., Hartung, H.P., Hertenstein, B., Karussis, D., Martino, G., Tyndall, A., van der Meché, F.G. J. Neurol. (2000) [Pubmed]
  19. Electrophysiological correlates of dementia. Comi, G., Leocani, L. Suppl. Clin. Neurophysiol (2000) [Pubmed]
  20. Review neuroimaging in amyotrophic lateral sclerosis. Comi, G., Rovaris, M., Leocani, L. Eur. J. Neurol. (1999) [Pubmed]
  21. Can evoked potentials be useful in monitoring multiple sclerosis evolution?. Comi, G., Locatelli, T., Leocani, L., Medaglini, S., Rossi, P., Martinelli, V. Electroencephalogr. Clin. Neurophysiol. Suppl (1999) [Pubmed]
  22. Electrophysiological investigations in multiple sclerosis dementia. Comi, G., Leocani, L., Locatelli, T., Medaglini, S., Martinelli, V. Electroencephalogr. Clin. Neurophysiol. Suppl (1999) [Pubmed]
  23. The Italian multicentre study on the prevalence of distal symmetric polyneuropathy: correlation between clinical variables and nerve conduction parameters. Italian Diabetic Neuropathy Committee. Comi, G., Fedele, D., Coscelli, C., Cucinotta, D., Feldman, E.L., Ghirlanda, G., Negrin, P., Santeusanio, F., Maderna, L. Electroencephalogr. Clin. Neurophysiol. Suppl (1999) [Pubmed]
 
WikiGenes - Universities